Notably, in contrast to TCR Vβ3 CD8+ T-cell frequencies, the frequencies of non-Vβ3 CD8+ T cells in the tumor were increased by the completion of C4 (Fig. 2F). The gene discussed is CD8A; the disease is neoplasm.